ABBV Jan 2025 140.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:25PM EDT. Market open.
| Previous close | 23.49 |
| Open | 21.28 |
| Bid | 20.85 |
| Ask | 21.25 |
| Strike | 140.00 |
| Expiry date | 2025-01-17 |
| Day's range | 21.10 - 21.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 370 |
Motley Fool3 Magnificent Dividend Stocks to Buy in October
There's no better time than October to invest in high-quality dividend stocks. Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October. Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).
ZacksPharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
ZacksAbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2023 Yahoo. All rights reserved.
